Trial Results Using News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trial Results Using. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trial Results Using Today - Breaking & Trending Today

I-Mab Announces Encouraging Phase 1b/2 Study Results of Patients with Advanced NSCLC Receiving Uliledlimab and Toripalimab Combination Therapy at ASCO 2023

Published: May 25, 2023

- Uliledlimab is a differentiated monoclonal antibody designed to target CD73 and promote stronger activation of patients' immune system against cancer cells....

Source: prnewswire.com

Related Topics:

United StatesHong KongQing ZhouLong WuSan DiegoAndrew ZhuRichard YehGigi FengGuangdong Academy Of Medical SciencesExchange CommissionPrnewswire The Company NasdaqGuangdong Lung Cancer InstituteAmerican Society Of Clinical OncologyClinical OncologyPrincipal InvestigatorGuangdong Provincial PeopleGuangdong AcademyMedical SciencesGuangdong Lung CancerToripalimab Combination TherapyTrial Results UsingPotential Predictive BiomarkerPrivate Securities Litigation Reform ActOperating OfficerChief Financial

I-Mab Announces Poster Presentation of Proprietary CD73 Antibody Uliledlimab at ASCO 2023

Published: April 26, 2023

/PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization...

Source: prnewswire.com

Related Topics:

United StatesQing ZhouHong KongSan DiegoMccormick PlaceGigi FengRichard YehExchange CommissionMccormick Place Convention CenterPrnewswire The Company NasdaqAmerican Society Of Clinical OncologyClinical OncologyAnnual MeetingToripalimab Combination TherapyTrial Results UsingPotential PredictiveGuangdong Provincial PeoplePrivate Securities Litigation Reform ActOperating OfficerChief FinancialI Mab